BackAntisense Therapeutics Limited Overview

Antisense Therapeutics Limited Receivables

Antisense Therapeutics Limited's receivables is $2.5M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.51M
↑ 51.29% YoYΔ $850607.00 vs prior year quarter

Peer trimmed avg / median

Loading

Antisense Therapeutics Limited Receivables History

Loading

Antisense Therapeutics Limited vs. peers: Receivables Comparison

Loading

Antisense Therapeutics Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Antisense Therapeutics Limited (ATHJF) FAQ

As of the most recent data (June 2024), ATHJF shows a receivables of $2.5M. That compares with $1.7M in the prior-year period — up 51.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATHJF's receivables is now $2.5M (was $1.7M) — a 51.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Antisense Therapeutics Limited is outperforming or lagging.

Tracking ATHJF's receivables over time shows whether Antisense Therapeutics Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $1.7M in the prior-year period — up 51.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Antisense Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $2.5M) with ownership activity and broader fundamentals.